Driving Integrity, Patient Safety, and Regulatory Compliance Across Clinical Studies
Ensure total Good Clinical Practice (GCP) compliance, reliable trial data collection, and flawless site execution with QCLYNX’s tailored quality and eClinical validation solutions. Built for clinical trial sponsors, principal investigators, and trial networks, our services safeguard subject safety, mitigate data collection risks, and ensure audit-ready study milestones from Phase I through post-market surveillance.
Compliance & Integrity Excellence for Modern Clinical Research
The clinical research ecosystem has transformed rapidly—evolving from paper-based site binders to decentralized clinical trials (DCTs), direct-to-patient digital tools, electronic informed consent (eConsent), and wearable health sensors. Despite these advances, global health authority scrutiny over trial data authenticity remains stringent. Regulatory agencies like the FDA, EMA, and health authorities enforce rigorous GCP standards, where unvalidated trial tools, missing consent tracking, or flawed data flows threaten to invalidate entire study datasets. Clinical study directors must maintain uncompromised data integrity while managing complex digital trial ecosystems. QCLYNX acts as a trusted global compliance partner. We turn clinical trial requirements into streamlined processes by delivering risk-based software assurance for eClinical tools, setting up robust clinical quality management systems, and ensuring continuous audit readiness for trial sites and sponsors.
Our Core Offerings
Trusted Services for Modern Clinical Research
eClinical Tool Validation (eConsent, eCOA/ePRO, Wearables)
Risk-based validation for patient-facing software, mobile health applications, eConsent tools, and digital biomarkers under FDA 21 CFR Part 11 and EU Annex 11.
Clinical Protocol & Data Integrity Assessments
Mapping raw clinical data flows from digital devices and site entries to the final clinical database to guarantee ALCOA+ standards.
GCP Quality Management System Setup & SOPs
Developing tailored GCP-compliant Quality Management Systems, clinical investigator trial master file SOPs, and monitoring protocols.
Site & Sponsor Audit Readiness (FDA BIMO Preparation)
Mock site inspections, sponsor compliance audits, clinical database reviews, and remediation for protocol deviations.
Decentralized Clinical Trial (DCT) Compliance Management
Establishing risk controls, remote data access governance, and vendor validation for hybrid and fully decentralized trial frameworks.
We are here to help you.
End-to-End Product Lifecycle Partnership
Building on proven life science leadership, QCLYNX empowers clinical research teams by applying modern compliance techniques and agile validation protocols. Driven by a commitment to advancing medicine safely, we partner with trial sponsors and research centers to keep clinical studies moving forward safely, efficiently, and with total regulatory integrity.
We implement end-to-end data encryption verification, role-based access controls, and time-stamped audit trail reviews to ensure remote patient data collection adheres to HIPAA, GDPR, Part 11, and GCP standards.
Yes. We conduct FDA CSA risk-based validation on mobile patient-reported outcome apps, electronic consent platforms, and sensor interfaces to verify software performance and data capture accuracy.
We audit source documentation, review investigator site files (ISF), verify informed consent logs, analyze protocol deviation tracking, and train site staff on handling inspector inquiries.
We validate Electronic Data Capture (EDC), eConsent, eCOA/ePRO systems, Clinical Trial Management Systems (CTMS), electronic Trial Master Files (eTMF), and safety reporting gateways.